Favourites   Have ideas?  Sign in / Register

Positive:   Disease: Neurology/Alzheimer/Parkinson's ↓10.19   Biopharma ↓9.35   RNA ↓8.78 «See more»   Disease: Central nervous system (CNS) ↓0.72   Food ↑0.7   Disease: Eye  ↑2.3

Negative:   Bad infrastructure  ↓7.16


Gene and cell segment

ABEO Abeona Therapeutics Inc. - Common Stock 0 + Gene and cell, Medicine

+ My List
AGTC Applied Genetic Technologies Corporation - Common Stock -6.67% up -7.11% 0.44 + Medicine, Gene and cell

+ My List
AKUS Akouos, Inc. - Common Stock -11.95% -11.95% 0 + Gene and cell, Disease: Ear/Nose, Medicine

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock -7.62% -7.62% 0 + Cancer fight, Gene and cell, Medicine

+ My List
APDN Applied DNA Sciences, Inc. - Common Stock -6.96% up -11.13% 4.17 + Medicine, Gene and cell

+ My List
ATHX Athersys, Inc. - Common Stock -5.56% up -7.27% 1.71 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares -4.33% up -7.09% 2.76 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVRO AVROBIO, Inc. - Common Stock -1.89% up -8.77% 6.88 + Gene and cell, Pain fight, Medicine

+ My List
AVXL Anavex Life Sciences Corp. - Common Stock -7.15% down -6.37% -0.78 + Gene and cell, Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
BBIO BridgeBio Pharma, Inc. - Common Stock -3.52% -3.52% 0 + Gene and cell


Last highlighted: $BBIO 📜 SEC Form 8-K filed https://t.co/oef6IdAzjQ #majorpharmaceuticals #healthcare
+ My List
BNGO Bionano Genomics, Inc. - Common Stock -7.32% -7.32% 0 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant 4.62% down 22.31% -17.69 + Cancer fight, Medicine, Gene and cell

+ My List
BNTC Benitec Biopharma Inc. - Common Stock -8.78% down -2.03% -6.75 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
CABA Cabaletta Bio, Inc. - Common Stock -1% up -9.05% 8.05 + Gene and cell, Medicine, Immunology

+ My List
CDXS Codexis, Inc. - Common Stock down 14.44% -14.44 + Medicine, Gene and cell

+ My List
CNTG Centogene N.V. - Common Shares -7.4% down -6.3% -1.1 + Gene and cell, Medicine


Last highlighted: #CNTG SEC report: Centogene N.V. Report of proposed sale of securities
SEC Filing Form 144 filed by Centogene N.V. -- SEC File Number 211084208
+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock -7.16% -7.16% 0 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DTIL Precision BioSciences, Inc. - Common Stock 0.7% up -7.24% 7.94 + Cancer fight, Gene and cell, Food

+ My List
DYN Dyne Therapeutics, Inc. - Common Stock -3.4% up -12.4% 9 + Gene and cell, Medicine


Last highlighted: #DYN SEC report: Dyne Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Dyne Therapeutics, Inc. -- SEC File Number
+ My List
EDIT Editas Medicine, Inc. - Common Stock -7.26% -7.26% 0 + Medicine, Gene and cell


Last highlighted: #EDIT SEC report: Editas Medicine, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Editas Medicine, Inc. -- SEC File Number 211142329
+ My List
EPZM Epizyme, Inc. - Common Stock 2.05% up -11.68% 13.73 + Cancer fight, Gene and cell

+ My List
EVLO Evelo Biosciences, Inc. - Common Stock -7.25% down -6.94% -0.31 + Medicine, Gene and cell

+ My List
FHTX Foghorn Therapeutics Inc. - Common Stock 4.36% up -7.78% 12.14 + Medicine, Gene and cell


Last highlighted: #FHTX SEC report: Foghorn Therapeutics Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Foghorn Therapeutics Inc. -- SEC File Number 211089297
+ My List
FREQ Frequency Therapeutics, Inc. - Common Stock -3.27% -3.27% 0 + Medicine, Disease: Ear/Nose, Gene and cell


Last highlighted: $FREQ 📜 SEC Form 8-K filed by Frequency Therapeutics, Inc. https://t.co/BVOsAkh3ww #majorpharmaceuticals #healthcare
+ My List
FRLN Freeline Therapeutics Holdings plc - ADSs 2.6% down 8.66% -6.06 + Medicine, Biotechnology, Gene and cell

+ My List
FULC Fulcrum Therapeutics, Inc. - Common Stock -7.15% down -3.94% -3.21 + Medicine, Gene and cell


Last highlighted: #FULC SEC report: Fulcrum Therapeutics, Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Fulcrum Therapeutics, Inc. -- SEC File Number 211160928
+ My List
GBIO Generation Bio Co. - Common stock 2.53% up -11.74% 14.27 + Gene and cell, Medicine


Last highlighted: #GBIO SEC report: Generation Bio Co. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Generation Bio Co. -- SEC File Number 211089285
+ My List
IGMS IGM Biosciences, Inc. - Common Stock -3.76% down 8.16% -11.92 + Biotechnology, Gene and cell, Medicine


Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock -6.53% up -7.31% 0.78 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -7.87% down -5.39% -2.48 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
LRMR Larimar Therapeutics, Inc. - Common Stock 0.77% down 10.08% -9.31 + Medicine, Gene and cell, Biotechnology

+ My List
MBIO Mustang Bio, Inc. - Common Stock -5.56% -5.56% 0 + Medicine, Gene and cell


Last highlighted: $MBIO 📜 SEC Form 8-K filed by Mustang Bio, Inc. https://t.co/rBa024MAHc #healthcare #majorpharmaceuticals
+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock -2.27% up -7.89% 5.62 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MYGN Myriad Genetics, Inc. - Common Stock 7.42% down 7.48% -0.06 + Gene and cell, Medicine, Women Health


Last highlighted: $MYGN SEC Filing: 8-K Earnings - MYRIAD GENETICS INC (0000899923) August 03 https://t.co/GlGu9uVj6k
+ My List
NBSE NeuBase Therapeutics, Inc. - Common Stock -0.72% up -7.07% 6.35 + Medicine, Gene and cell


Last highlighted: #NBSE SEC report: NeuBase Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by NeuBase Therapeutics, Inc. -- SEC File Number 211078875
+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -8.93% -8.93% 0 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
ORGS Orgenesis Inc. - Common Stock -7.07% -7.07% 0 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
+ My List
ORTX Orchard Therapeutics plc - American Depositary Shares -1.57% up -7.97% 6.4 + Medicine, Gene and cell


Last highlighted: #ORTX SEC report: Orchard Therapeutics plc Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Orchard Therapeutics plc -- SEC File Number 211142307
+ My List
PASG Passage Bio, Inc. - Common Stock -7.59% down -6.69% -0.9 + Gene and cell, Medicine


Last highlighted: #PASG SEC report: Passage BIO, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by Passage BIO, Inc. -- SEC File Number 211102754
+ My List
PGEN Precigen, Inc. - Common Stock -11.57% -11.57% 0 + Biopharma, Gene and cell, Medicine


Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock -10.29% -10.29% 0 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine


Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets
+ My List
PROG Progenity, Inc. - Common Stock -12.73% -12.73% 0 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PSTX Poseida Therapeutics, Inc. - Common Stock 0.89% up -11.78% 12.67 + Medicine, Gene and cell


Last highlighted: #PSTX SEC report: Poseida Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Poseida Therapeutics, Inc. -- SEC File Number
+ My List
RGNX REGENXBIO Inc. - Common Stock -6.78% up -8.13% 1.35 + Gene and cell, Biotechnology, Medicine

+ My List
RNA Avidity Biosciences, Inc. - Common Stock 6.72% down 7.43% -0.71 + Medicine, Gene and cell


Last highlighted: #RNA SEC report: Avidity Biosciences, Inc. Prospectus [Rule 424(b)(5)]
SEC Filing Form 424B5 filed by Avidity Biosciences, Inc. -- SEC File Number 211136619
+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock -3.68% up -7.09% 3.41 + Gene and cell, Cancer fight, Medicine

+ My List
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock 0.45% up -7.6% 8.05 + Pharmaceutical , Gene and cell, Medicine


Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945
+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock -7.31% -7.31% 0 + Gene and cell, Medicine, Cancer fight

+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock 8.86% up 6.54% 2.32 + Gene and cell, Disease: Central nervous system (CNS), Medicine

+ My List
XCUR Exicure, Inc. - Common Stock 0 + Gene and cell, Medicine


Last highlighted: $XCUR 8-K Exicure (12 May, 4:13pm) 📰 Exicure, Inc. Reports First Quarter 2021 Financial Results and Corporate Progress https://t.co/VEYCSavonT #XCUR #8K #Exicure #News
+ My List
FDMT 4D Molecular Therapeutics, Inc. - Common Stock 2.3% down 7.38% -5.08 + Medicine, Gene and cell, Disease: Eye

+ My List
LGVN Longeveron Inc. - common stock -17.86% -17.86% 0 + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.